KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

GoodRx Holdings (GDRX) Shares Outstanding (2019 - 2026)

GoodRx Holdings' Shares Outstanding history spans 7 years, with the latest figure at $341.1 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding fell 10.91% to $341.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $341.1 million, a 10.91% decrease, with the full-year FY2025 number at $341.1 million, down 10.91% from a year prior.
  • Shares Outstanding hit $341.1 million in Q4 2025 for GoodRx Holdings, roughly flat from $341.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding for GDRX hit a ceiling of $400.6 million in Q4 2021 and a floor of $105.9 million in Q4 2024.
  • Historically, Shares Outstanding has averaged $369.8 million across 5 years, with a median of $394.7 million in 2021.
  • Biggest five-year swings in Shares Outstanding: soared 71.58% in 2021 and later decreased 10.91% in 2025.
  • Tracing GDRX's Shares Outstanding over 5 years: stood at $400.6 million in 2021, then dropped by 0.88% to $397.0 million in 2022, then decreased by 0.74% to $394.1 million in 2023, then fell by 2.86% to $382.8 million in 2024, then dropped by 10.91% to $341.1 million in 2025.
  • Business Quant data shows Shares Outstanding for GDRX at $341.1 million in Q4 2025, $341.2 million in Q3 2025, and $352.8 million in Q2 2025.